(Q42970796)

English

Rituximab-lenalidomide-dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma

scientific article published on September 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Rituximab-lenalidomide-dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

11

object named as

Didier Blaise

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Vadim Ivanov

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Emeline Tabouret

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Guillaume Chuto

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Bruno Chetaille

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hacène Fezoui

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Diane Coso

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jerome Rey

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Therese Aurran-Schleinitz

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jean Marc Schiano

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Anne Marie Stoppa

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Reda Bouabdallah

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1758-1760

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

The evolution of thalidomide and its IMiD derivatives as anticancer agents

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497886

21 January 2018

Identifiers

10.3109/10428194.2010.497886

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42970796&oldid=2098395235"